Patents by Inventor William Tieu

William Tieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RADIOPHARMACEUTICALS
    Publication number: 20250352678
    Abstract: This application relates generally to prostate specific membrane antigen (PSMA) targeting compounds which may be complexed to a radioisotope. Pharmaceutical compositions including such compounds also disclosed. Such compounds or pharmaceutical compositions may be used in nuclear medicine for the in-vivo imaging of various tissues, and the treatment and/or prevention of various PSMA-expressing cancers, especially prostate cancer.
    Type: Application
    Filed: July 24, 2025
    Publication date: November 20, 2025
    Inventors: Simon PUTTICK, William TIEU, Kevin KUAN
  • Radiopharmaceuticals
    Patent number: 12419977
    Abstract: This application relates generally to prostate specific membrane antigen (PSMA) targeting compounds which may be complexed to a radioisotope. Pharmaceutical compositions including such compounds also disclosed. Such compounds or pharmaceutical compositions may be used in nuclear medicine for the in-vivo imaging of various tissues, and the treatment and/or prevention of various PSMA-expressing cancers, especially prostate cancer.
    Type: Grant
    Filed: November 14, 2024
    Date of Patent: September 23, 2025
    Assignee: AdvanCell Isotopes Pty Limited
    Inventors: Simon Puttick, William Tieu, Kevin Kuan
  • RADIOPHARMACEUTICALS
    Publication number: 20250064994
    Abstract: This application relates generally to prostate specific membrane antigen (PSMA) targeting compounds which may be complexed to a radioisotope. Pharmaceutical compositions including such compounds also disclosed. Such compounds or pharmaceutical compositions may be used in nuclear medicine for the in-vivo imaging of various tissues, and the treatment and/or prevention of various PSMA-expressing cancers, especially prostate cancer.
    Type: Application
    Filed: November 14, 2024
    Publication date: February 27, 2025
    Inventors: Simon PUTTICK, William TIEU, Kevin KUAN
  • Antimicrobial compounds
    Patent number: 9108978
    Abstract: A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: August 18, 2015
    Assignees: Monash University, Adelaide Research & Innovation Pty Ltd
    Inventors: Andrew Abell, Steven Polyak, Grant Booker, John Wallace, Tatiana Soares da Costa, Angie Jarrad, William Tieu, Kelly Lee Keeling, Daniel Sejer Pedersen, Nicole Pendini, Matthew Wilce, Min Yin Yap
  • NOVEL ANTIMICROBIAL COMPOUNDS
    Publication number: 20140296177
    Abstract: A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    Type: Application
    Filed: September 21, 2012
    Publication date: October 2, 2014
    Inventors: Andrew Abel, Steven Polyak, Grant Booker, John Wallace, Tatiana Soares Da Costa, Angie Jarrad, William Tieu, Kelly Lee Keeling, Daniel Sejer Pederson, Nicole Pendini, Matthew Wilce, Min Yin Yap